By Porter Wright on The December 4, 2006 on-line edition of the Proceedings of the National Academy of Sciences is set to publish findings from a recent in vivo animal study researching the possible health effects of SWCNTs deliberately injected into the bloodstream. Scientists at Rice University and the University of Texas are said to have found that carbon nanotubes are … Continue Reading
By Porter Wright on Rick Weiss reported in yesterday’s Washington Post that the EPA plans to regulate silver nanomaterials used in consumer products as "germ-killing" agents: The decision — which will affect the marketing of high-tech odor-destroying shoe liners, food-storage containers, air fresheners, washing machines and a wide range of other products that contain tiny bacteria-killing particles of silver … Continue Reading
By Porter Wright on An October report authored by Michael R. Taylor, Esq., former FDA Deputy Commissioner for Policy (1991-1994) may not be warmly received by all nanomanufacturers. Taylor’s report focuses on what he sees as FDA’s three primary purposes in relation to nanotechnology: (1) ensure product safety; (2) foster innovation; and (3) maintain public confidence in nanoproducts. Taylor … Continue Reading
By Porter Wright on In the September 2006 edition of Nanotechnology Law & Business, two (2) employees of FDA’s Center for Drug Evaluation and Research (“CDER”) — Nakissa Sadrieh and Parvaneh Espandiari — published “Nanotechnology and the FDA: What Are the Scientific and Regulatory Considerations for Products Containing Nanomaterials?” The article begins with a disclaimer that the authors’ views … Continue Reading
